Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

609 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Not Yet Recruiting

Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study

NCT05067530

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie, Oddział Onkologii Klinicznej i Immunoonkologii z Pododdziałem Dziennym Poznan, Greater Poland Voivodeship, Poland
  • Dolnośląskie Centrum Onkologii we Wrocławiu, Oddział Onkologii Klinicznej/Chemioterapii, Poradnia Chemioterapii; Leczenie Nowotworów Piersi Wroclaw, Lower Silesian Voivodeship, Poland
  • Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Warsaw, Masovian Voivodeship, Poland
  • SP ZOZ Opolskie Centrum Onkologii im. Prof. Tadeusza Koszarowskiego Opole, Opole Voivodeship, Poland
View Trial Details
Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details
Completed

Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.

NCT05181462

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
  • Hospital Universitario Clinico San Cecilio Granada, Andalusia, Spain
  • Complejo Hospitalario de Jaén Jaén, Andalusia, Spain
  • Hospital Universitario Virgen De La Victoria Málaga, Andalusia, Spain
View all 23 locations
View Trial Details
Completed

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

NCT03797326

Conditions
Adnexal Diseases, Advanced Solid Tumors, Astrocytoma, +49 more
Locations
  • City of Hope ( Site 0002) Duarte, California, United States
  • Cedars Sinai Medical Center ( Site 0003) Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center ( Site 0005) Sacramento, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 0007) Aurora, Colorado, United States
View all 88 locations
View Trial Details
Completed

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

NCT04085276

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • The Fifth Medical Center of PLA General Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Peking University Shougang Hospital Beijing, Beijing Municipality, China
View all 55 locations
View Trial Details
Completed

Ruxolitinib for Premalignant Breast Disease

NCT02928978

Conditions
Adenocarcinoma, Atypical Ductal Hyperplasia, Atypical Lobular Hyperplasia, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details

Related conditions